Ireland - English - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - lidocaine hydrochloride; fluorescein sodium - eye drops, solution - 4%w/v +0.25 percent weight/volume - colouring agents; fluorescein, combinations

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see dosage and administration (2.2)]. limitations of use not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see dosage and administration (2.2), contraindications (4), warnings and precautions (5.1, 5.4, 5.5, 5.7, 5.9)] . bupivacaine hydrochloride injection/bupivacaine hydrochloride and epinephrine injection is contraindicated

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - lidocaine hydrochloride monohydrate 10 mg/ml;  ; methylprednisolone acetate 40 mg/ml - injection (depot) - 40 mg/ml - active: lidocaine hydrochloride monohydrate 10 mg/ml   methylprednisolone acetate 40 mg/ml - depo-medrol with lidocaine by intra-synovial of soft tissue administration (including periarticular and intrabursal) is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: · synovitis of osteoarthritis · rheumatoid arthritis · acute gouty arthritis · epicondylitis · acute nonspecific tenosynovitis · post-traumatic osteoarthritis · acute and subacute bursitis

United States - English - NLM (National Library of Medicine)

coopersurgical, inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lugol’s is a topical antiseptic. strong iodine solution is a germicide and fungicide. lugol’s is preservative-free. iodide preparations are contraindicated in patients with known sensitivity to the drugs. astringyn® is a styptic agent used for achieving local hemostasis. in punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 one method for applying ferric subsulfate solution for dermal use consists

United States - English - NLM (National Library of Medicine)

rx pharma-pack, inc. - povidone-iodine (unii: 85h0hzu99m) (iodine - unii:9679tc07x4) - iodine 10 mg in 1 ml - intramuscular where oral therapy is not feasible, injectable corticosteroid therapy, including kenalog-40 injection and kenalog-80 injection (triamcinolone acetonide injectable suspension, usp) are indicated for intramuscular use as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyper

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - fluorescein sodium; lidocaine hydrochloride - eye drops, solution - colouring agents; fluorescein, combinations

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. intramuscular where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, peren

Canada - English - Health Canada

baxter corporation - povidone-iodine; tetracaine (tetracaine hydrochloride); lidocaine hydrochloride; dextrose - liquid - 10%; 1%; 1%; 10% - povidone-iodine 10%; tetracaine (tetracaine hydrochloride) 1%; lidocaine hydrochloride 1%; dextrose 10% - local anesthetics

Canada - English - Health Canada

baxter corporation - povidone-iodine; tetracaine hydrochloride; lidocaine hydrochloride; dextrose; epinephrine - kit - 10%; 20mg; 1%; 10%; 1ml - povidone-iodine 10%; tetracaine hydrochloride 20mg; lidocaine hydrochloride 1%; dextrose 10%; epinephrine 1ml - local anesthetics

United States - English - NLM (National Library of Medicine)

coopersurgical, inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - xylocaine (lidocaine hcl) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. ferric subsulfate, aqueous, is a stypic agent used for achieving local hemostasis. in punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 one method of applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edge of the wound and stretching the skin. the wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension main